Biotechnology company and drug delivery platform
innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this
morning announced that it has identified improved performance features of a new
version of the DehydraTECH(TM) delivery platform primarily suitable for use in
solid oral dosage forms like capsules, tablets and pills for the
pharmaceutical, medical, and supplement markets. The company’s groundbreaking
use of a naturally sourced formulation enhancement more than doubles
DehydraTECH’s absorption performance compared to prior results. During the
company’s animal study, Lexaria tested its DehydraTECH delivery technology with
compounds postulated to behave in a synergistic fashion for enhancement of
gastro-intestinal absorption, which resulted in significantly enhanced
DehydraTECH performance. This new, enhanced DehydraTECH formulation delivers 8X
more CBD into blood and over 19X more CBD into brain tissue than standard
industry formulations. In addition, Lexaria has filed new patent applications
related to the recent innovations. The specific nature of the enhanced
DehydraTECH will remain undisclosed until the new patent filings are published
for proprietary reasons.
To view the full press release, visit http://ibn.fm/38QF0
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its
disruptive delivery technology, which promotes healthier ingestion methods,
lower overall dosing and higher effectiveness of lipophilic active molecules.
Lexaria has multiple patents pending in over 40 countries around the world and
has patents granted in the United States and Australia for utilization of its
DehydraTECH delivery technology. Lexaria’s technology provides increases in
intestinal absorption rates, more rapid delivery to the bloodstream, and
important taste-masking benefits for orally administered bioactive molecules
including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs
(NSAIDs), nicotine and other molecules. For more information, visit the
company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates
relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment